MedPath

广州一品红制药有限公司

Ownership
-
Established
2010-07-16
Employees
-
Market Cap
-
Website
http://www.gdyph.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

59

NMPA:59

Drug Approvals

Dexmedetomidine Hydrochloride Injection

Product Name
盐酸右美托咪定注射液
Approval Number
国药准字H20254416
Approval Date
Jun 3, 2025
NMPA

Ketorolac Trometamol Injection

Product Name
酮咯酸氨丁三醇注射液
Approval Number
国药准字H20254156
Approval Date
May 13, 2025
NMPA

Amlodipine Besylate Tablets

Product Name
苯磺酸氨氯地平片
Approval Number
国药准字H20253097
Approval Date
Jan 8, 2025
NMPA

Mecobalamin Injection

Product Name
甲钴胺注射液
Approval Number
国药准字H20253118
Approval Date
Jan 8, 2025
NMPA

Amlodipine Besylate Tablets

Product Name
苯磺酸氨氯地平片
Approval Number
国药准字H20253096
Approval Date
Jan 8, 2025
NMPA

Carbocysteine Oral Solution

Product Name
羧甲司坦口服溶液
Approval Number
国药准字H20247300
Approval Date
Dec 3, 2024
NMPA

Linezolid for Oral Suspension

Product Name
利奈唑胺干混悬剂
Approval Number
国药准字H20249523
Approval Date
Dec 1, 2024
NMPA

Olmesartan Medoxomil Orally Disintegrating Tablets

Product Name
奥美沙坦酯口崩片
Approval Number
国药准字H20244148
Approval Date
Jun 25, 2024
NMPA

Argatroban Injection

Product Name
阿加曲班注射液
Approval Number
国药准字H20244043
Approval Date
Jun 18, 2024
NMPA

Troxerutin for Injection

Product Name
注射用曲克芦丁
Approval Number
国药准字H20041041
Approval Date
May 14, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.